A Study to Evaluate Screening Biomarkers for Lung Cancer


About this study

The purpose of this study is to evaluate new and complementary analytical MS technologies to identify and define the metabolic biomarkers for lung cancer.


Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria: 

  • Patients 18 or older years old.
  • Patients with planned surgery for Non-small Cell Lung Cancer (NSCLC) confirmed cancer.
  • Able to sign consent.
  • Able to complete with specimen collection directions.

Exclusion Criteria: 

  • Individuals less than 18 years old.
  • Patients with metastatic disease from another primary.



Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Si Pham, M.D.

Closed-enrolling by invitation

What is this? (?)
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Chandler Chapman B.S., M.P.H.

(904) 953-8681


More information


Publications are currently not available

Mayo Clinic Footer